Based on our observation that disruption of PUFA biosynthesis leads to STING activation and subsequent AML cell death, we next investigated whether STING activation was sufficient to phenocopy FADS1 inhibition on AML biology, using a STING agonist, diAZBI (30). Here, STING1 is linked to acute myeloid leukemia.